Outcomes
| Patient/sex . | Engraftment ANC* . | Engraftment Platelets* . | Acute GVHD . | Chronic GVHD . | Status prior to allo . | Status after allo . | Current status, d . | Cause of death . |
|---|---|---|---|---|---|---|---|---|
| 1/M | 15 | 14 | 0 | 0 | CR | CR | CCR 769+ | — |
| 2/F | 14 | 22 | 3 | Ext | PR | CR | CCR 448+ | — |
| 3/M | 22 | 24 | 2 | 0 | PR | CR | CCR 444+ | — |
| 4/M | 17 | 33 | 2 | Lim | PR | PR | PR 440+ | — |
| 5/F | 13 | 24 | 1 | 0 | NC | PR† | PR 430+ | — |
| 6/M | 15 | 12 | 1 | Lim | PR | CR | PR 419+ | — |
| 7/M | 13 | 22 | 0 | 0 | PR | CR | Dead 119 | Cardiac arrest |
| 8/F | 16 | 15 | 1 | 0 | NC | MR2-153 | MR 298+ | — |
| 9/M | 21 | 35 | 4 | NE | PD | PR | Dead 105 | GVHD |
| 10/M | 18 | NE | 0 | NE | NC | NE | Dead 56 | Aspergillus |
| 11/M | 23 | 23 | 0 | 0 | PD | PR | PD, alive 341+ | — |
| 12/M | 13 | 11 | 3 | Ext | PD | CR | Dead 110 | Sepsis |
| 13/M | 24 | 20 | 1 | Lim | PD | CR | CCR 403+ | — |
| 14/F | 16 | 22 | 1 | 0 | PD | PR | PD, alive 265+ | — |
| 15/F | 17 | 36 | 1 | 0 | PR | CR | PD, alive 266+ | — |
| 16/F | 17 | 24 | 2 | Lim | PD | PR† | PR 199+ | — |
| 17/F | 11 | 17 | 1 | 0 | PD | PR‡ | PR 190+ | — |
| 18/M | 14 | 18 | 0 | NE | PR | PR‡ | PR 100+ | — |
| 19/M | 12 | 12 | 2 | 0 | MR | PR‡ | PR 163+ | — |
| 20/F | 10 | 12 | 1 | NE | PR | PR‡ | PR 127+ | — |
| 21/M | 18 | 31 | 4 | NE | PD | PD | Dead 64 | GVHD, renal failure |
| Patient/sex . | Engraftment ANC* . | Engraftment Platelets* . | Acute GVHD . | Chronic GVHD . | Status prior to allo . | Status after allo . | Current status, d . | Cause of death . |
|---|---|---|---|---|---|---|---|---|
| 1/M | 15 | 14 | 0 | 0 | CR | CR | CCR 769+ | — |
| 2/F | 14 | 22 | 3 | Ext | PR | CR | CCR 448+ | — |
| 3/M | 22 | 24 | 2 | 0 | PR | CR | CCR 444+ | — |
| 4/M | 17 | 33 | 2 | Lim | PR | PR | PR 440+ | — |
| 5/F | 13 | 24 | 1 | 0 | NC | PR† | PR 430+ | — |
| 6/M | 15 | 12 | 1 | Lim | PR | CR | PR 419+ | — |
| 7/M | 13 | 22 | 0 | 0 | PR | CR | Dead 119 | Cardiac arrest |
| 8/F | 16 | 15 | 1 | 0 | NC | MR2-153 | MR 298+ | — |
| 9/M | 21 | 35 | 4 | NE | PD | PR | Dead 105 | GVHD |
| 10/M | 18 | NE | 0 | NE | NC | NE | Dead 56 | Aspergillus |
| 11/M | 23 | 23 | 0 | 0 | PD | PR | PD, alive 341+ | — |
| 12/M | 13 | 11 | 3 | Ext | PD | CR | Dead 110 | Sepsis |
| 13/M | 24 | 20 | 1 | Lim | PD | CR | CCR 403+ | — |
| 14/F | 16 | 22 | 1 | 0 | PD | PR | PD, alive 265+ | — |
| 15/F | 17 | 36 | 1 | 0 | PR | CR | PD, alive 266+ | — |
| 16/F | 17 | 24 | 2 | Lim | PD | PR† | PR 199+ | — |
| 17/F | 11 | 17 | 1 | 0 | PD | PR‡ | PR 190+ | — |
| 18/M | 14 | 18 | 0 | NE | PR | PR‡ | PR 100+ | — |
| 19/M | 12 | 12 | 2 | 0 | MR | PR‡ | PR 163+ | — |
| 20/F | 10 | 12 | 1 | NE | PR | PR‡ | PR 127+ | — |
| 21/M | 18 | 31 | 4 | NE | PD | PD | Dead 64 | GVHD, renal failure |
NE indicates not evaluable; CCR: continuous complete remission; Ext, extensive disease; Lim, limited disease; and —, patient still alive. Other abbreviations are explained in Table 1.
Days to absolute neutrophil count (ANC) greater than 1 × 109/L, platelets greater than 20 × 109/L.
Only positive for immunofixation.
Currently still decreasing monoclonal bands.
The patient had persistent disease on day 120 and received a donor lymphocyte infusion with now decreasing monoclonal bands.